CalciMedica, Inc.

Calcimedica, Inc.

Biotechnology • Healthcare • La Jolla, CA, United States • CALC (NCM)

CalciMedica, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for illnesses caused by inflammatory and immunologic processes and direct cellular damage. The company's lead product candidate comprises Auxora, an intravenous formulated small molecule calcium release-activated calcium (CRAC) channel inhibitors for the treatment of acute pancreatitis, asparaginase-induced pancreatic toxicity, and acute kidney injury, as well as severe COVID-19 pneumonia. It also develops Auxora for the treatment of acute ulcerative colitis, traumatic brain injury, and allergic asthma; and oral CRAC channel inhibitors for use in chronic inflammatory indications. The company is based in La Jolla, California.

858 952 5500 505 Coast Boulevard South, La Jolla, CA 92037, United States

Stock Performance (90 Days)

Data through Dec 26, 2025
Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

CalciMedica Reports Third Quarter 2025 Financial Results and Provides Clinical & Corporate Updates - PR Newswire
PR Newswire • Nov 12
Oppenheimer reiterates Outperform rating on CalciMedica stock ahead of key trial - Investing.com
Investing.com • Dec 2
Investment Calculator: Estimate Potential Returns - NerdWallet
NerdWallet • Nov 12
CalciMedica, Inc. (CALC): Among Penny Stocks with Insider Buying in 2025 - Yahoo Finance
Yahoo Finance • Mar 4
How to Calculate the Value of Your Stock Options - Business.com
Business.com • Nov 10

Other Biotechnology Companies

View All →
CODEXIS, INC. logo Codexis, Inc.
1 layoff tracked
$144.5M market cap
VERTEX PHARMACEUTICALS INC / MA logo Vertex Pharmaceuticals Inc. / MA
$118.68B market cap
REGENERON PHARMACEUTICALS, INC. logo Regeneron Pharmaceuticals, Inc.
$82.72B market cap
ALNYLAM PHARMACEUTICALS, INC. logo Alnylam Pharmaceuticals, Inc.
$52.92B market cap
ARGENX SE logo Argenx SE
$52.62B market cap
INSMED Inc logo Insmed Inc.
$37.61B market cap

Frequently Asked Questions

Has CalciMedica, Inc. had layoffs?
No layoff events have been recorded for CalciMedica, Inc. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.
How many employees does CalciMedica, Inc. have?
CalciMedica, Inc. has approximately 15 employees.
What industry is CalciMedica, Inc. in?
CalciMedica, Inc. operates in the Biotechnology industry, within the Healthcare sector.
Is CalciMedica, Inc. a publicly traded company?
Yes, CalciMedica, Inc. is publicly traded under the ticker symbol CALC on the NCM. The company has a market capitalization of approximately $0.09 billion.
Where is CalciMedica, Inc. headquartered?
CalciMedica, Inc. is headquartered in La Jolla, CA, United States at 505 Coast Boulevard South, La Jolla, CA 92037, United States.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.